Exodus Point Capital Management, LP Celularity Inc Transaction History

Exodus Point Capital Management, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$0.43 - $4.31 $7,195 - $72,119	-16,733 Closed	0 $0
Q2 2022 Aug 19, 2022	SELL	$2.81 - $12.91 $111,500 - $512,268	-39,680 Reduced 70.34%	16,733 $57,000
Q1 2022 May 13, 2022	BUY	$3.81 - $9.79 $128,202 - $329,423	33,649 Added 147.82%	56,413 $491,000
Q4 2021 Feb 11, 2022	BUY	$4.64 - $7.46 $105,624 - $169,819	22,764 New	22,764 $117,000

23.6M

Ticker CELU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,424,000
Market Cap $395M
Description
Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. It operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. The company's lead therapeutic programs include CYCART-19, a placental-de...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.